Plasma Progastrin-releasing peptide (ProGRP) level well predicts the degree and duration of PSA response in patients with metastatic castration-resistant prostate cancer underwent...

by M. Yashi, M. Yokoyama, H. Fuchizawa, N. Okubo, R. Kurashina, K. Takei, I. Suzuki, K. Sakamoto, A. Nukui, Y. Fukabori, T. Kamai
Published 2020-07-01